Rose Pharma-Sponsored Patient Preference Research Accepted for Presentation at ObesityWeek® 2026

PRESS RELEASE Research examines patient preferences for…

Presenting Phase 2a Results of ROSE-010 at Obesity Week 2025

PRESS RELEASE Rose Pharma Inc. to Present Positive Phase 2a…